Research Articles | Page 4 | Aplastic Anemia & MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes Aug 2012 Am J Hematol myelodysplastic syndromes (MDS)
Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia. Oct 2013 Am J Hematol aplastic anemia
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: A treatment versus no-treatment study Dec 2015 Am J Hematol paroxysmal nocturnal hemoglobinuria (PNH)
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution. Oct 2013 Am J Hematol myelodysplastic syndromes (MDS)
Evaluation of revised IPSS cytogenetic risk stratification and prognostic impact of monosomal karyotype in 783 patients with primary myelodysplastic syndromes. May 2013 Am J Hematol myelodysplastic syndromes (MDS)
Clinical Outcomes in Adult Patients with Aplastic Anemia- a single institution experience Aug 2017 Am J Hematol aplastic anemia
Validation of the revised international prognostic scoring system in treated patients with myelodysplastic syndromes. Apr 2013 Am J Hematol myelodysplastic syndromes (MDS)
Impact of Achievement of Complete Cytogenetic Response on Outcome in Patients with Myelodysplastic Syndromes Treated with Hypomethylating Agents Jan 2017 Am J Hematol myelodysplastic syndromes (MDS)
Prolonged cyclosporine administration after antithymocyte globulin delays but does not prevent relapse in severe aplastic anemia Jun 2014 Am J Hematol aplastic anemia
Calculator-free point-of-care prognostication in myelodysplastic syndromes. Jan 2019 Am J Hematol myelodysplastic syndromes (MDS)